Michigan’s Department of Licensing and Regulatory Affairs (LARA) has announced that cerebral palsy will join the list of medical conditions that make patients eligible for enrollment in the state’s medical marijuana program. Its addition, approved by unanimous decision and announced on Monday, expands the number of qualifying conditions in the state to 28.
The most common qualifying condition cited by the 292,905 patients in the state’s medical marijuana program is chronic pain, followed by muscle spasms and severe nausea. 41,000 care providers are licensed to provide Michiganders with cannabis to help managing the symptoms of cancer, HIV/AIDS, PTSD, wasting syndrome, and various other conditions.
Past studies have proven that medical cannabis can have tremendous effects on the symptoms of cerebral palsy. Tel Aviv’s Wolson Medical Center hosted a study of 36 children with the condition, many who had high levels of motor disorders. They were treated with two kinds of cannabis oil, one with a THC-CBD ratio of 1:6 and another of 1:20. Within three to four months, doctors reported in 2017 that motor function, pain symptoms, and bowel movements had all improved in study participants.
A 2011 study conducted by the National Institutes of Health found that the use